The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis

N/ARecruitingNCT06194344

The University of Texas Health Science Center, Houston40 enrolled

Overview

The purpose of this study is to see how feasible is the use of compact EEG and paired audio technology to administer sleep interventions for inpatients with psychosis, to see if individuals that receive individualized technology-based sleep interventions experience improvements in sleep quality and to see if individuals that receive individualized technology-based sleep interventions experience improvements in symptomatology

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Psychosis

Interventions

Individualized imageryBEHAVIORAL

Study personnel will assist participants to create scripts that foster relaxation and safety. Objects, places, and/or scenarios that foster participant relaxation, sense of safety, and/or positive emotions will be identified. Participants will write or type the generated scenario using highly detailed elements (e.g., including visual, olfactory, auditory, tactile, and gustatory sensations, as applicable) associated with the imagery. Study personnel will assist with recording the imagery scripts; audio files will be recorded using an audio recording application. The imagery scripts will be played at night via Bluetooth earbuds connected to the Muse app and script recording while laying down to sleep. The imagery rehearsal prompts will play for approximately 15 minutes, based on 10-20-minute recommendations across imagery rehearsal therapy (IRT) studies

ControlBEHAVIORAL

Participants will wear the earbuds, with use of Muse S headband to collect outcome data without the individualized imagery scripts.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * primary diagnoses of schizophrenia spectrum disorder or mood disorder with psychotic features, as determined by the treatment team or record review * capacity to consent to the study as determined by licensed psychologists ( or the primary attending psychiatrist * reported sleep dysfunction which will be determined by a subthreshold or more severe score ≥ 8 on the Insomnia Severity Index (ISI), and/or report experiencing nightmares at least once a week. Exclusion Criteria: * primary substance- or medical-induced psychosis * intellectual and developmental disabilities * neurodegenerative cognitive disorders * implanted devices (e.g., Pacemakers) * on one-to-one supervision or 15-minute safety checks for suicidality or aggression * patients with roommates that are on 15-minute checks to minimize impact on study participants' awakenings

Locations (1)

The University of Texas Health Science Center at Houston

Houston, Texas, United States

RECRUITING

Outcomes

Primary Outcomes

Feasibility as assessed by coding percentage of use per night (based on duration of physiological measures collected per night divided by hours of sleep)

Time frame: from start of intervention to end of intervention (upto 80 days after baseline )

Feasibility as assessed by percentage of nights used for the duration of the intervention.

Time frame: from start of intervention to end of intervention (upto 80 days after baseline )

Feasibility as assessed by a self-report satisfaction survey, Was It Worth It questionnaire

The measure will consist of 7 items rated on a 5-point Likert scale ranging from Strongly Disagree (1) to Strongly Agree (5), for a maximum score of 35,higher number indicating better satisfaction

Time frame: post-intervention(upto 80 days after baseline )

Secondary Outcomes

Improvements in sleep quality as assessed by the Insomnia Severity Index (ISI)

The ISI is an instrument comprising seven questions, and each is scored from 0-7 for a score range of 0-28, a higher number indicating severe clinical insomnia